atorvastatin has been researched along with eye in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Erkiliç, K; Koç, A; Mistik, S; Ozkiris, A | 1 |
Camsari, UM; Ekerbicer, N; Gurpinar, T; Guvendi, G; Sisman, AR; Uysal, N | 1 |
Gómara, MJ; Haro, I; Sánchez-López, E | 1 |
1 trial(s) available for atorvastatin and eye
Article | Year |
---|---|
Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy.
Topics: Atorvastatin; Blood Flow Velocity; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Eye; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Ophthalmic Artery; Pyrroles; Retinal Artery; Triglycerides | 2007 |
2 other study(ies) available for atorvastatin and eye
Article | Year |
---|---|
Statins reduce testicular and ocular VEGF: A potential compromise to microcirculation.
Topics: Angiogenesis Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Eye; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microcirculation; Neovascularization, Pathologic; Rats, Wistar; Testis; Vascular Endothelial Growth Factor A | 2018 |
Atorvastatin-loaded peptide amphiphiles against corneal neovascularization.
Topics: Atorvastatin; Corneal Neovascularization; Drug Liberation; Eye; Humans; Peptides | 2023 |